Supplier Info.
Report Item
Your report on Product(s) will be sent to EC21 Administrators once submitted.
Then, Administrators will investigate and then take appropriate actions.
Contact Supplier
Product name: Pomalidomide
CAS: 19171-19-8
MF:C13H11N3O4
MW:273.24
Description: Pomalidomide (INN, originally CC-4047 or 3-amino-thalidomide, trade name Pomalyst in the US) is a derivative of thalidomide marketed by Celgene. It is anti-angiogenic and also acts as an immunomodulator. Pomalidomide was approved in February 2013 by the U.S. Food and Drug Administration (FDA) as a treatment for relapsed and refractory multiple myeloma.
| Registration Date | 2014/05/27(Year/Month/Date) |
|---|---|
| Buyer / Seller in EC21 | Seller |
| Business Type | Manufacturer |
| Year established | 2007 |
| Employees total | 501 - 1000 |
| Annual revenue | USD 10,000,001 - 50,000,000 |
| Company | Vision Hubei Pharmaceutical Co., Ltd. |
|---|---|
| Address | Huangli road 38WuhanHubeiChina |
| Phone | 86 - 027 - 9023113 |
| Contact | tianyue wu |